This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:cancer [09.06.2018] – [25-hydroxyvitamin D] sallieq | home:diseases:cancer [09.06.2018] – [Are There Concerns About Over-supplementing with Vitamin D?] sallieq | ||
---|---|---|---|
Line 61: | Line 61: | ||
* However, emerging observational data suggest that adverse outcomes may occur at much lower levels, such as in the 50-75 ng/mL range. These suspected adverse outcomes appear to include increases in all-cause mortality and increases in the rate of heart disease and some cancers. | * However, emerging observational data suggest that adverse outcomes may occur at much lower levels, such as in the 50-75 ng/mL range. These suspected adverse outcomes appear to include increases in all-cause mortality and increases in the rate of heart disease and some cancers. | ||
- | from | + | |
- | [[https:// | + | |
====1, | ====1, | ||
Mawer //et al.// reported that 1,25-D is such a sensitive indicator of the immune response that it can even be used to determine prognosis in breast cancer with bone metastasis.(({{pubmed> | Mawer //et al.// reported that 1,25-D is such a sensitive indicator of the immune response that it can even be used to determine prognosis in breast cancer with bone metastasis.(({{pubmed> | ||
- | --> | + | |
- | </ | + | |
Line 287: | Line 285: | ||
* [[http:// | * [[http:// | ||
* [[https:// | * [[https:// | ||
+ | * [[https:// | ||
* [[http:// | * [[http:// | ||
* [[http:// | * [[http:// |